Characterization of α₂-macroglobulin from plasma of cystic fibrosis patients and controlsBACK, S. A; ALHADEF, J. A.Biochemical medicine. 1983, Vol 30, Num 1, pp 34-42, issn 0006-2944Article

Preclinical safety profile of plasma prepared using the INTERCEPT Blood SystemCIARAVINO, V; MCCULLOUGH, T; CIMINO, G et al.Vox sanguinis (Basel. 1956). 2003, Vol 85, Num 3, pp 171-182, issn 0042-9007, 12 p.Article

Plasma fibronectin time course in burned patients: influence of sepsisEKINDJIAN, O. G; MARIEN, M; WASSERMANN, D et al.The Journal of trauma. 1984, Vol 24, Num 3, pp 214-219, issn 0022-5282Article

The Plasma Lipidomic Signature of Nonalcoholic SteatohepatitisPURI, Puneet; WIEST, Michelle M; WATKINS, Steven M et al.Hepatology (Baltimore, Md.). 2009, Vol 50, Num 6, pp 1827-1838, issn 0270-9139, 12 p.Article

PLASMA CLEARANCE AND ENDOCYTOSIS OF MITOCHONDRIAL MALATE DEHYDROGENASE IN THE RATBIJSTERBOSCH MK; DUURSMA AM; BOUMA JMW et al.1981; BIOCHEM. J. (LOND.); ISSN 0006-2936; GBR; DA. 1981; VOL. 200; NO 1; PP. 115-121; H.T. 2; BIBL. 33 REF.Article

Development of a radioimmunoassay for bovine pepsinogen ASIDIKOU, D. I; REMY, B; BECKERS, J. F et al.Revue d'élevage et de médecine vétérinaire des pays tropicaux. 2005, Vol 58, Num 4, pp 229-235, issn 0035-1865, 7 p.Article

DIFFERENTIATION OF A MYOCARDIAL DEPRESSANT FACTOR PRESENT IN SHOCK PLASMA FROM KNOWN PLASMA PEPTIDES AND SALTS = DIFFERENCIATION DES PEPTIDES ET SELS CONNUS DU PLASMA D'UN FACTEUR DEPRIMANT LE MYOCARDE PRESENT DANS LE PLASMA DE CHOCLEFER AM; INGE TF JR.1973; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1973; VOL. 142; NO 2; PP. 429-433; BIBL. 18REF.Serial Issue

TRANSPORTE DE LIPIDOS EN EL PLASMA = TRANSPORT DES LIPIDES DANS LE PLASMANARANJO A.1971; REV. ECUAT. MED. CI. BIOL.; ECUAD.; DA. 1971; VOL. 9; NO 1-2; PP. 38-47; BIBL. 1 P. 1/2Serial Issue

CONCENTRATION AND DISTRIBUTION OF HUMAN PLASMA APOLIPOPROTEIN EMACKIE A; CASLAKE MJ; PACKARD CJ et al.1981; CLIN. CHIM. ACTA; ISSN 0009-8981; NLD; DA. 1981; VOL. 116; NO 1; PP. 35-45; BIBL. 23 REF.Article

The Human Plasma LipidomeQUEHENBERGER, Oswald; DENNIS, Edward A.The New England journal of medicine. 2011, Vol 365, Num 19, pp 1812-1823, issn 0028-4793, 12 p.Article

Intérêt du Plasma enrichi en Plaquettes (PRP). dans les thérapeutiques actuelles: application au sein d'un cabinet de médecine et dermatologie esthétiqueBIOULAC, B.Journal de médecine esthétique et de chirurgie dermatologique. 2011, Vol 38, Num 151, pp 147-151, issn 0249-6380, 5 p.Article

Fibrinogen Foxton : A novel BpA277V mutation causing low normal plasma fibrinogen concentrationDAVIS, Ryan L; BAKER, Bartrum; BRENNAN, Stephen O et al.Thrombosis and haemostasis. 2008, Vol 100, Num 4, pp 708-710, issn 0340-6245, 3 p.Article

Circulating folic acid in plasma : relation to folic acid fortificationKALMBACH, Renee D; CHOUMENKOVITCH, Silvina F; TROEN, Aron M et al.The American journal of clinical nutrition. 2008, Vol 88, Num 3, pp 763-768, issn 0002-9165, 6 p.Article

Recent methodological advances in the mass spectrometric analysis of free and protein-associated 3-nitrotyrosine in human plasmaTSIKAS, Dimitrios; CAIDAHL, Kenneth.Journal of chromatography. B. 2005, Vol 814, Num 1, pp 1-9, issn 1570-0232, 9 p.Article

Sécurisation des médicaments dérivés du plasma vis-à-vis des nouveaux agents infectieuxPIOTROWICZ-THEIZEN, D.La Revue de médecine interne (Paris). 2005, Vol 26, pp 29-31, issn 0248-8663, 3 p., HS1Conference Paper

Enhancement of fibrinolytic activity of human plasma in the presence of acetoneADAMUS, K; PAJDAK, W.Scandinavian journal of clinical & laboratory investigation. 1994, Vol 54, Num 5, pp 353-359, issn 0036-5513Article

Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography : application to plasma pharmacokinetic studies in cancer patientsBARILERO, I; GANDIA, D; ARMAND, J.-P et al.Journal of chromatography. Biomedical applications. 1992, Vol 575, Num 2, pp 275-280, issn 0378-4347Article

Détection des complexes solubles de fibrine = Detection of soluble fibrin in plasmaPOTRON, G; DROULLE, C.STV. Sang thrombose vaisseaux. 1992, Vol 4, Num 5, pp 325-327, issn 0999-7385Article

Einsatz von FFP im operativen Bereich unter besonderer Berücksichtigung des Eigen-FFpHEIM, M. U; MEMPEL, W.Infusionstherapie (1988). 1990, Vol 17, pp 34-36, issn 1011-6966, SUP2Article

Rapid high-performance liquid chromatographic determination of suramin in plasma of patients with acquired immune deficiency syndrome (AIDS) or AIDS-related complex (ARC)TEIRLYNCH, O; BOGAERT, M. G; DEMEDTS, P et al.Journal of pharmaceutical and biomedical analysis. 1989, Vol 7, Num 1, pp 123-126, issn 0731-7085Article

ABC of transfusion : national self-sufficiency in blood and blood productsGUNSON, H. H.British medical journal (1857). 1989, Vol 299, Num 6714, pp 1514-1516, issn 0007-1447, 3 p.Article

A functional test for protein S activity in plasmaVAN DE WAART, P; PREISSNER, K. T; BECHTOLD, J. R et al.Thrombosis research. 1987, Vol 48, Num 4, pp 427-437, issn 0049-3848Article

Transfusion pattern of fresh frozen plasma in a medical school hospitalSHAIKH, B. S; WAGAR, D; LAU, P. M et al.Vox sanguinis (Basel. 1956). 1985, Vol 48, Num 6, pp 366-369, issn 0042-9007Article

Plasma glutathione in health and in patients with malignant diseaseBEUTLER, E; GELBART, T.The Journal of laboratory and clinical medicine. 1985, Vol 105, Num 5, pp 581-584, issn 0022-2143Article

In vitro degradation of atracurium in human plasmaSTILLER, R. L; RYAN COOK, D; CHAKRAVORTI, S et al.British Journal of Anaesthesia. 1985, Vol 57, Num 11, pp 1085-1088, issn 0007-0912Article